Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.42%12.64B | 6.19%11.77B | 5.69%3.11B | 9.21%3.16B | 13.80%3.05B | -4.56%2.45B | 7.99%11.08B | 18.44%2.94B | 5.52%2.89B | 2.41%2.68B |
| Cost of revenue | 8.57%8.93B | 0.76%8.23B | -6.81%2.16B | 13.23%2.2B | 5.72%2.17B | -8.34%1.7B | 9.33%8.17B | 22.47%2.32B | -0.34%1.94B | 9.30%2.05B |
| Gross profit | 4.76%3.71B | 21.40%3.54B | 51.95%951.67M | 0.95%954.69M | 40.08%882.22M | 5.26%752.89M | 4.41%2.92B | 5.57%626.32M | 20.02%945.75M | -15.03%629.81M |
| Operating expense | 5.31%2.83B | 1.00%2.69B | -9.28%631.12M | 8.99%727.22M | 1.07%662.45M | 3.77%667.72M | 11.89%2.66B | 21.70%695.69M | 8.34%667.26M | 9.54%655.42M |
| Staff costs | 0.19%1.37B | -6.94%1.36B | ---- | ---- | ---- | ---- | 15.86%1.46B | ---- | ---- | ---- |
| Selling and administrative expenses | 12.72%379.77M | 2.98%336.91M | ---- | ---- | ---- | ---- | -7.47%327.17M | ---- | ---- | ---- |
| -Selling and marketing expense | -2.36%11.17M | -9.97%11.44M | ---- | ---- | ---- | ---- | 24.34%12.71M | ---- | ---- | ---- |
| -General and administrative expense | 13.25%368.61M | 3.50%325.47M | ---- | ---- | ---- | ---- | -8.41%314.47M | ---- | ---- | ---- |
| Other operating expenses | 9.85%1.09B | 13.64%988.61M | ---- | ---- | ---- | ---- | 14.29%869.97M | ---- | ---- | ---- |
| Operating profit | 3.01%878.62M | 234.06%852.94M | 562.09%320.55M | -18.32%227.46M | 958.13%219.77M | 18.60%85.17M | -38.47%255.32M | -421.23%-69.37M | 61.83%278.49M | -117.92%-25.61M |
| Net non-operating interest income (expenses) | 82.94%-1.19M | -71.91%-7M | -58.95%-1.97M | -134.26%-1.6M | -129.46%-2.91M | 41.02%-519K | -59.26%-4.07M | -37.32%-1.24M | -450.81%-683K | -21.26%-1.27M |
| Non-operating interest income | 380.05%6.02M | 68.64%1.25M | 4.87%323K | 42.70%391K | 57.80%172K | 605.77%367K | 48.01%743K | 113.89%308K | 3.79%274K | 62.69%109K |
| Non-operating interest expense | -12.61%7.21M | 71.40%8.25M | 48.19%2.29M | 108.05%1.99M | 123.78%3.08M | -4.94%886K | 57.41%4.81M | 47.85%1.55M | 146.65%957K | 23.76%1.38M |
| Net investment income | 135.37%72.57M | -40.35%30.83M | -2,612.36%-14.92M | 3.15%37.34M | -446.11%-8.41M | 23.67%16.83M | 1,095.05%51.69M | 96.24%-550K | 283.06%36.2M | 191.87%2.43M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -40.50%28.51M | 47.92M | 0 | 0 | 0 | |||||
| Income from associates and other participating interests | -72.89%1.59M | 301.13%5.86M | -82.47%597K | 571.84%7.32M | 75.88%-899K | -12.14%-1.16M | -118.89%-2.91M | 630.37%3.41M | -139.24%-1.55M | -164.40%-3.73M |
| Special income (charges) | 36.28%-5.85M | -101.54%-9.18M | -4,700.00%-9.66M | -100.01%-83K | 108.32%622K | -100.72%-55K | 35.55%595.96M | -99.95%210K | 428,571.22%595.58M | -195.99%-7.48M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | -38.15%-595.44M | --0 | ---- | ---- |
| Less:Other special charges | 121.35%8.95M | 889.45%4.04M | 2,255.24%4.53M | 162.88%83K | -455.36%-622K | 194.83%55K | 93.95%-512K | -180.00%-210K | 48.84%-132K | 98.67%-112K |
| Less:Write off | -160.38%-3.1M | --5.13M | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -88.48%4.75M | -14.57%41.25M | 3.40%10.43M | 29.61%12.12M | -30.19%9.33M | -39.48%9.37M | -8.86%48.28M | -31.36%10.09M | -13.34%9.35M | 15.01%13.37M |
| Income before tax | 1.70%979M | 1.95%962.63M | 630.84%305.02M | -69.20%282.57M | 1,291.48%265.43M | 2.82%109.62M | 2.10%944.27M | -112.73%-57.46M | 367.98%917.38M | -113.55%-22.28M |
| Income tax | -7.29%255.85M | 76.72%275.98M | 7,669.70%82.83M | -14.18%84.88M | 2,326.76%84.52M | -54.93%23.76M | -7.59%156.17M | -92.39%1.07M | 53.62%98.9M | -93.28%3.48M |
| Net income | 5.32%723.15M | -12.87%686.65M | 479.65%222.2M | -75.85%197.69M | 802.28%180.9M | 59.29%85.86M | 4.27%788.1M | -113.38%-58.53M | 521.73%818.48M | -122.89%-25.76M |
| Net income continuous operations | 5.32%723.15M | -12.87%686.65M | 479.65%222.19M | -75.85%197.69M | 802.26%180.9M | 59.29%85.86M | 4.27%788.1M | -113.38%-58.53M | 521.73%818.48M | -122.89%-25.76M |
| Noncontrolling interests | 93.98%23.98M | 375.42%12.36M | 137.58%2.21M | -67.75%1.77M | 222.95%13.46M | -136.39%-5.08M | 300.62%2.6M | -32.23%-5.89M | 85.73%5.48M | -253.59%-10.95M |
| Net income attributable to the company | 3.69%699.17M | -14.16%674.29M | 517.93%219.98M | -75.90%195.92M | 1,230.51%167.44M | 127.68%90.94M | 4.02%785.5M | -111.91%-52.64M | 531.72%813M | -112.81%-14.81M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3.69%699.17M | -14.16%674.29M | 517.93%219.98M | -75.90%195.92M | 1,230.51%167.44M | 127.68%90.94M | 4.02%785.5M | -111.91%-52.64M | 531.72%813M | -112.81%-14.81M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 3.70%651.1 | -14.15%627.87 | 518.15%204.85 | -75.90%182.43 | 1,230.60%155.91 | 127.70%84.68 | 4.02%731.32 | -111.91%-48.99 | 531.76%756.91 | -112.81%-13.79 |
| Diluted earnings per share | 3.70%651.1 | -14.15%627.87 | 518.00%204.85 | -75.90%182.43 | 1,230.52%155.8984 | 127.70%84.68 | 4.02%731.32 | -111.91%-49.0069 | 531.74%756.8886 | -112.81%-13.79 |
| Dividend per share | 0.00%220 | 10.00%220 | 20.00%120 | 0 | 0.00%100 | 0 | 0.00%200 | 0.00%100 | 0 | 0.00%100 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |